Envista Holdings
S&P 400
$25.55
-1.24%
Delayed · cached 15 min
Peer comparison
| Company | Price↕ | Market Cap↕ | P/E↕ | P/B↕ | ROE %↕ | ROCE %↕ | Div yield %↕ | Valuation |
|---|---|---|---|---|---|---|---|---|
| West Pharmaceutical Services | $ 346.23 | $24.37B | 44.27 | 8.15 | 16.51 | 17.09 | 0.25 | Above FV |
| Align Technology | $ 150.82 | $10.71B | 26.18 | 2.54 | 9.70 | 12.13 | 0.00 | Above FV |
| Cooper Companies (The) | $ 53.91 | $10.25B | 18.53 | 1.23 | 4.50 | 5.91 | 0.00 | Above FV |
| Lantheus Holdings | $ 100.25 | $6.55B | 23.98 | 4.99 | 17.80 | 14.93 | 0.00 | Above FV |
| Merit Medical Systems, Inc. | $ 86.36 | $5.16B | 35.54 | 3.07 | 7.65 | 7.04 | 0.00 | Above FV |
| Haemonetics | $ 102.69 | $4.67B | 49.61 | 5.58 | 11.62 | 7.53 | 0.00 | Above FV |
| Envista Holdings | $ 25.55 | $4.10B | 44.05 | 1.33 | 1.53 | 4.55 | 0.00 | Above FV |
| ICU Medical | $ 156.48 | $3.91B | 131.50 | 1.82 | 0.03 | 1.23 | 0.00 | Above FV |
| Neogen | $ 11.78 | $2.57B | -294.50 | 1.23 | -0.38 | -0.68 | 0.00 | — |
| Dentsply Sirona | $ 10.46 | $2.09B | -3.49 | 1.59 | -44.26 | -10.93 | 3.05 | — |
| BioLife Solutions, Inc. | $ 34.95 | $1.71B | 34.95 | 4.07 | -1.09 | -3.91 | 0.00 | — |
| Avanos Medical, Inc. | $ 24.99 | $1.16B | -15.92 | 1.52 | -9.32 | -6.96 | — | — |
Price, market cap, P/E, P/B and dividend yield reflect the live quote (delayed, cached 15 min); ROE/ROCE from reported financials. The highlighted row is the current company. Click a column header to sort. Educational data only.
How to read the peer comparison
This table places the company beside others in the same industry on a few common measures. Comparison adds context that a single company's numbers cannot give on their own.
- Valuation multiples like P/E and P/B are most meaningful within the same industry, because different industries naturally trade at different levels. Comparing a company only to its peers is more useful than to the whole market.
- Return measures (ROE, ROCE) show how efficiently each company turns capital into profit. A company well ahead of or behind its peers here is worth understanding.
- No single column decides anything. A beginner reads the row across — valuation, returns, and size together — and treats the highlighted current company as one data point among its peers.
- Use the sortable headers to rank peers on any measure, but remember that "cheaper" or "higher" on one metric is a starting question, not an answer.
Educational only — not a recommendation to buy, sell, or hold any security.